Coronary Segment to Lead Cardiac Microcatheter Market Share During 2023–2028

According to our latest study on "Cardiac Microcatheter Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Indication and End User," the market was valued at US$ 332.97 million in 2022 and is likely to reach US$ 487.20 million by 2028; it is estimated to record a CAGR of 6.8% from 2023 to 2028. The cardiac microcatheter market size is likely to surge by 2028, owing to the high prevalence of cardiovascular diseases and growing use of percutaneous coronary intervention for treatment of chronic total occlusions.

Microcatheter is defined as a small diameter catheter that is used in minimally invasive procedures for delivering devices. Its small build makes it ideal for navigating complex vasculature within the human body. It is used for guidewire support, exchanges, to access distal anatomy, cross lesions, deliver therapeutic embolic, inject contrast media, and perform other procedures in complex endovascular procedures. Microcatheters are also commonly used in percutaneous coronary intervention (PCI).

Based on indication, the cardiac microcatheter market size is bifurcated into coronary and general peripheral vascular. The coronary segment held the largest market share in 2022 and is anticipated to register the higher CAGR during the forecast period. Cardiovascular diseases are a group of disorders associated with abnormalities in the heart and blood vessels. This category includes commonly observed heart conditions such as cerebrovascular disease, coronary heart disease, peripheral arterial disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism. PCI has gained popularity among cardiologists across the world for bifurcation lesions, ostial location, tortuous anatomy, angled takeoffs, coronary calcification, and CTO. Microcatheters—both single-lumen and double-lumen microcatheters (DLMs)—play an essential part in the tool kit while treating complex lesions. Microcatheter selection involves a detailed understanding of the microcatheter specification, lesion anatomy, lesion location, vessel tortuosity and trajectory, and crossing techniques.

Based on end user, the cardiac microcatheter market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment held a largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period. Hospitals serve a significant role by providing extensive medical services to patients suffering from various diseases. The segment's growth is majorly attributed to the increasing number of hospitals with advanced facilities, rising focus on offering superior patient experience, and growing preference of patients to opt hospitals to get treatment for coronary conditions. Also, increasing government funding in hospitals and growing hospital research drive the market growth. According to the Definitive Healthcare data, as of August 2020, there were 7,247 active hospitals in the US. The hospitals in the country embrace state-of-the-art medical technology, encourage new physicians, and are often the point of entry to healthcare for the uninsured. The increasing number of hospitals, improvements in reimbursement policies, and surging incidences of cardiovascular diseases are expected to drive the cardiac microcatheter market.

Based on geography, the cardiac microcatheter market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. The market in North America is further segmented into the US, Canada, and Mexico. The cardiac microcatheter market in Europe is sub segmented into France, Germany, the UK, the Netherlands, Italy, and the Rest of Europe. The APAC cardiac microcatheter market is further segmented into China, India, Japan, Australia, Thailand, and the Rest of APAC. The market in the MEA is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the MEA. The South & Central America cardiac microcatheter market is sub segmented into Brazil, Argentina, and the Rest of South & Central America. 

Boston Scientific Corp, Teleflex Inc, Medtronic Plc, OrbusNeich Medical Group Holdings Ltd, Asahi Intecc USA Inc, Merit Medical Systems Inc, Nipro Corp, Terumo Corp, Tokai Medical Products Inc, Integer Holdings Corp are among the leading companies operating in the cardiac microcatheter market.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com